50
https://pubmed.ncbi.nlm.nih.gov/38094716
A patient with hereditary hemorrhagic telangiectasias and high cardiac output failure was successfully treated with bevacizumab after delivering her baby.
https://pubmed.ncbi.nlm.nih.gov/38094716
A patient with hereditary hemorrhagic telangiectasias and high cardiac output failure was successfully treated with bevacizumab after delivering her baby.